TAFAMIDIS

/static/temp/default.svg Search structure
Trade Names
Synonyms
Status
Molecule Category Free-form
ATC N07XX08
UNII 8FG9H9D31J
EPA CompTox DTXSID00208185

Structure

InChI Key TXEIIPDJKFWEEC-UHFFFAOYSA-N
Smiles O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1
InChI
InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)

Physicochemical Descriptors

Property Name Value
Molecular Formula C14H7Cl2NO3
Molecular Weight 308.12
AlogP 4.5
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 2.0
Polar Surface Area 63.33
Molecular species ACID
Aromatic Rings 3.0
Heavy Atoms 20.0

Pharmacology

Mechanism of Action Action Reference
Transthyretin stabiliser STABILISER PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Secreted protein
- 410 3-370 - 99
EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Homo sapiens
- 410-981 3-370 - 99
Rattus norvegicus
- - - - 0

Target Conservation

Protein: Transthyretin
Description: Transthyretin
Organism : Homo sapiens
P02766 ENSG00000118271

Cross References

Resources Reference
ChEBI 78538
ChEMBL CHEMBL2103837
DrugBank DB11644
DrugCentral 4192
FDA SRS 8FG9H9D31J
Guide to Pharmacology 8378
PDB 3MI
PubChem 11001318
SureChEMBL SCHEMBL442508
ZINC ZINC000043206271
CONTENTS